But now scientists and entrepreneurs are redoubling their efforts to recreate the sense of odor in compact units that detect and analyze odors much like the best way cameras now acknowledge our faces and microphones our phrases. In pursuit of those high-tech units–which might use odors to detect illness like most cancers or Covid-19, find hidden explosives or decipher our moods and behaviors—some corporations are leveraging advances in artificial biology and genetic engineering. Others are harnessing advances in synthetic intelligence.
“It’s completely a rising area,” says Andreas Mershin, an odor-sensor researcher at the Massachusetts Institute of Technology. “We’re recognizing that there’s a whole world of molecules we’re blind to.” He calls the sector an “unexplored goldmine.”
The quest to build better olfactory sensors is a challenging one because odors are made up of many different chemicals and because animals’ olfactory receptors—specialized cells in the nose that recognize odor molecules—are remarkably diverse. Humans have three types of receptors for color vision, for instance, but hundreds of different olfactory receptors.
Among the most futuristic devices are those that incorporate living cells engineered to react to specific odor components. Koniku Inc., a startup in San Rafael, Calif., is now using bioengineered nerve cells as the basis for sensors capable of recognizing the subtle odors of explosives. The cells contain proteins designed to detect so-called volatile organic compounds, carbon-containing substances that seep into the air from a range of sources, including food, paints, beverages, bodies and unexploded bombs.
“We design smell cyborgs,” says Osh Agabi, founder and chief govt of the agency. He says the agency is working with Airbus Americas to develop sensors to be used at airports to detect packages and baggage containing explosives. The objective is to not substitute bomb-sniffing canines and different safety measures now in use however to reinforce them, in response to Bruce Coole, head of aviation-security packages at Airbus Americas.
In current exams at San Francisco International Airport, a prototype of Koniku’s bomb-sniffing gadget recognized items of planted baggage identified to comprise explosives with an accuracy of 97%, in response to Dr. Agabi. In separate exams, Koniku’s sensors matched skilled canines’ potential to detect explosives, he says, including that the corporate can be creating sensors to be used in healthcare and different industries.
“When you take a look at the dimensions of what number of compounds or what number of smells are impacting human life which are but to be cataloged, we have now barely scratched the floor,” Dr. Agabi says.
Aromyx Corp., a startup in Mountain View, Calif., can be utilizing cells to create odor sensors. But somewhat than promoting units, it gives meals and wine producers a lab-based service to assist them higher perceive the precise odor molecules that drive client preferences. Company employees pair consumer-survey knowledge on individuals’s likes and dislikes with how Aromyx’s bioengineered odor-detecting cells react to sure odor molecules to give you desire profiles.
“The worth will not be within the sensor, however within the knowledge,” says Josh Silverman, Aromyx’s chief executive.
MIT’s Dr. Mershin is focusing on medical applications of olfaction technology. Inspired by dogs that have demonstrated an ability to sniff out malignancies in humans, he’s working on an artificial-intelligence odor-detection system to detect prostate cancer.
In 2021, Dr. Mershin’s team published results showing that their system matched trained dogs’ ability to detect prostate cancer in the urine of patients with the disease. Since then the team has increased the software’s accuracy to more than 90%, Dr. Mershin says, adding that the system is more reliable than the well-known prostate-specific antigen (PSA) blood test, which can lead to false-positive diagnoses. Only 25% of men who undergo a prostate biopsy following a suspicious PSA finding are later found to have cancer, according to the National Cancer Institute.
Olfaction experts warn that a series of scientific and technical challenges must be overcome before high-tech odor detectors are ready for broad penetration into the marketplace. For systems that use living cells, it will be important to monitor how often devices need to be replaced and how accuracy stacks up over long time frames, they say.
“The idea is great. It’s the implementation that’s the problem,” says Nathan Lewis, a chemist and olfaction-sensor developer on the California Institute of Technology.
Scientists and knowledge rights consultants say the emergence of subtle molecular surveillance—for instance. turning cell telephones into what some consultants name “odor telephones” capable of spotting medical conditions— raises thorny questions of privacy. After all, odors our bodies constantly emit contain clues about our health and personal choices, including the products we use and the foods we eat as well as our drinking and smoking habits and more. The collection and analysis of human olfactory data could affect some insurance coverage, for example, as well as employment, according to legal experts.
“We’re not prepared for the implications,” says David Carroll, an affiliate professor of media design on the Parsons School of Design and a data-rights activist. “It’s going to convey up deep and profound moral quandaries.”
Catch all of the Technology News and Updates on Live Mint.
Download The Mint News App to get Daily Market Updates & Live Business News.
More
Less
Subscribe to Mint Newsletters
* Enter a sound e mail
* Thank you for subscribing to our publication.
First article
